Filter
576
Filtered Results: 576
Text search:
Medikamente
Featured
Recommendations
75
New Publications
104
Language
Document type
No document type
268
Studies & Reports
93
Guidelines
84
Fact sheets
40
Brochures
37
Resource Platforms
19
Strategic & Response Plan
12
Manuals
8
Training Material
8
Infographics
3
Dashboards/Maps
1
Situation Updates
1
App
1
Online Courses
1
Countries / Regions
Germany
178
Western and Central Europe
29
Global
22
Senegal
14
Indonesia
14
Congo, Democratic Republic of
12
Eastern Europe
12
Benin
11
Burkina Faso
9
Cameroon
6
Haiti
6
Africa
5
Latin America and the Carribbean
5
Togo
3
Mozambique
3
Guinea-Bissau
3
France
3
Mali
3
Angola
3
Switzerland
2
Colombia
2
Ukraine
2
Sierra Leone
2
Malawi
2
Guinea
2
Venezuela
2
West and Central Africa
2
Côte d’Ivoire / Ivory Coast
2
Liberia
2
Ecuador
2
India
2
Rwanda
1
Nigeria
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Asia
1
Tanzania
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Luxembourg
1
Belgium
1
East and Southern Africa
1
South Africa
1
Uganda
1
Djibouti
1
Romania
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
122
Clinical Guidelines
30
Public Health
14
Women & Child Health
9
Pharmacy & Technologies
6
Key Resources
5
Capacity Building
4
Toolboxes
Refugee
193
Mental Health
60
TB
51
COVID-19
34
Global Health Education
34
Malaria
32
NCDs
24
Pharmacy
17
NTDs
10
HIV
9
Caregiver
8
Planetary Health
8
Ebola & Marburg
7
Health Financing Toolbox
6
Conflict
5
Rapid Response
4
Zika
3
AMR
3
Specific Hazards
1
Natural Hazards
1
Polio
1
Le Plan Stratégique National de Lutte contre le Paludisme au Cameroun 2019–2023 vise à réduire l’incidence et la mortalité liées au paludisme dans tout le pays, en mettant l’accent sur les groupes les plus vulnérables comme les enfants de moins de 5 ans et les femmes enceintes. Il repose...
This guide helps pharmacists to understand their role in the hypertension program. From maintaining hypertensive drug stock, to drug dispensing, to recording and reporting, to awareness generation with patients.
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Estimated annual number of deaths from drug use disorders, by type of drug.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
Estimated annual number of deaths from drug use disorders per 100,000 people.
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
Infection and Drug Resistance 2020:13 4047–4060
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Severe Malaria Observatory (SMO) is a global knowledge platform designed to enable professionals working on severe malaria, such as researchers, clinicians, public health experts, programme managers, policymakers and technical partners, to access, share and analyse reliable data on malaria compl...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa and Asia, the consortium conducted over 25 studies...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agents such as chloroquine and quinine to newer a...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme...
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two artemisinin-based combination therapies (ACTs) for...
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
